492 related articles for article (PubMed ID: 17591524)
21. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis.
Jeruc J; Vizjak A; Rozman B; Ferluga D
Am J Kidney Dis; 2006 Sep; 48(3):410-8. PubMed ID: 16931214
[TBL] [Abstract][Full Text] [Related]
23. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
[TBL] [Abstract][Full Text] [Related]
24. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells.
Ancuta P; Wang J; Gabuzda D
J Leukoc Biol; 2006 Nov; 80(5):1156-64. PubMed ID: 17056766
[TBL] [Abstract][Full Text] [Related]
25. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
26. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
Martinez-Lostao L; Ordi-Ros J; Balada E; Segarra-Medrano A; Majó-Masferrer J; Labrador-Horrillo M; Vilardell-Tarrés M
Lupus; 2007; 16(7):483-8. PubMed ID: 17670846
[TBL] [Abstract][Full Text] [Related]
27. Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles.
Zuniga R; Markowitz GS; Arkachaisri T; Imperatore EA; D'Agati VD; Salmon JE
Arthritis Rheum; 2003 Feb; 48(2):460-70. PubMed ID: 12571856
[TBL] [Abstract][Full Text] [Related]
28. Detection of urinary macrophages expressing the CD16 (Fc gamma RIII) molecule: a novel marker of acute inflammatory glomerular injury.
Hotta O; Yusa N; Ooyama M; Unno K; Furuta T; Taguma Y
Kidney Int; 1999 May; 55(5):1927-34. PubMed ID: 10231456
[TBL] [Abstract][Full Text] [Related]
29. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
[TBL] [Abstract][Full Text] [Related]
30. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells.
Zhang X; Wei H; Wang H; Tian Z
Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873
[TBL] [Abstract][Full Text] [Related]
31. Expression of proliferating cell associated protein, Ki-67, supports cellular proliferation in WHO Class IV lupus nephritis.
Cheah PL; Kunaseegaran R; Looi LM
Malays J Pathol; 2001 Jun; 23(1):27-30. PubMed ID: 16329544
[TBL] [Abstract][Full Text] [Related]
32. Quantitative gene expression analysis of fractalkine using laser microdissection in biopsies from kidney allografts with acute rejection.
Pietrzyk MC; Banas B; Wolf K; Rümmele P; Woenckhaus M; Hoffmann U; Krämer BK; Fischereder M
Transplant Proc; 2004 Nov; 36(9):2659-61. PubMed ID: 15621116
[TBL] [Abstract][Full Text] [Related]
33. Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.
Hasegawa M; Sato S; Echigo T; Hamaguchi Y; Yasui M; Takehara K
Ann Rheum Dis; 2005 Jan; 64(1):21-8. PubMed ID: 15608300
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
35. Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.
Matsunawa M; Isozaki T; Odai T; Yajima N; Takeuchi HT; Negishi M; Ide H; Adachi M; Kasama T
Arthritis Rheum; 2006 Nov; 54(11):3408-16. PubMed ID: 17075825
[TBL] [Abstract][Full Text] [Related]
36. Intrarenal cytokine gene expression in lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Lai KB; Li PK; Szeto CC
Ann Rheum Dis; 2007 Jul; 66(7):886-92. PubMed ID: 17324967
[TBL] [Abstract][Full Text] [Related]
37. Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis.
Yamada M; Yagita H; Inoue H; Takanashi T; Matsuda H; Munechika E; Kanamaru Y; Shirato I; Tomino Y; Matushima K; Okumura K; Hashimoto H
Arthritis Rheum; 2002 Mar; 46(3):735-40. PubMed ID: 11920409
[TBL] [Abstract][Full Text] [Related]
38. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.
do Nascimento AP; Viana Vdos S; Testagrossa Lde A; Leon EP; Borba EF; Barros RT; Bonfá E
Arthritis Rheum; 2006 May; 54(5):1568-72. PubMed ID: 16645990
[TBL] [Abstract][Full Text] [Related]
40. Tubulo-interstitial involvement in lupus nephritis with emphasis on pathogenesis.
Jeruc J; Jurcić V; Vizjak A; Hvala A; Babic N; Kveder R; Praprotnik S; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):702-6. PubMed ID: 11020960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
